Item 1(a). | Name of Issuer: |
Provention Bio, Inc. (the “Issuer”)
Item 1(b). | Address of Issuer’s Principal Executive Offices: |
55 Broad Street, 2nd Floor
Red Bank, New Jersey 07701
Item 2(a). | Names of Persons Filing: |
The names of the persons filing this report (collectively, the “Reporting Persons”) are:
| 1. | Sessa Capital (Master), L.P. |
| 4. | Sessa Capital IM GP, LLC |
Item 2(b). | Address of Principal Business Office or, if None, Residence: |
The address of the principal business office of each of the Reporting Persons is:
888 Seventh Avenue, 30th Floor
New York, NY, 10019
Sessa Capital (Master), L.P. – a Cayman Islands exempted limited partnership;
Sessa Capital GP, LLC – a Delaware limited liability company
Sessa Capital IM, L.P. – a Delaware limited liability partnership
Sessa Capital IM GP, LLC – a Delaware limited liability company
John Petry – a United States citizen
Item 2(d). | Title of Class of Securities: |
Common Stock, par value $0.0001 per share (“Common Stock”)
74374N102
Item 3. | If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: |
Not applicable.